Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis. (Q42619270)
Jump to navigation
Jump to search
scientific article published on 3 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis. |
scientific article published on 3 May 2007 |
Statements
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis (English)
C A E Walsh
P Minnock
C Slattery
F Pang
B Bresnihan